Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123363) titled 'Effect of Bitopertin on the Liver and on Levels of Protoporphyrin IX in Bile, Blood, Liver, and Stool in Patients With Erythropoietic Protoporphyria/X-linked Protoporphyria and Increased Liver Stiffness and/or Liver Enzymes at Baseline' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Wake Forest University Health Sciences
Condition:
Protoporphyria
Intervention:
Drug: bitopertin
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2025
...